SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-09-179829
Filing Date
2009-08-21
Accepted
2009-08-21 16:30:14
Documents
5
Effectiveness Date
2009-08-21

Document Format Files

Seq Description Document Type Size
1 FORM S-8 ds8.htm S-8 38935
2 OPINION OF COOLEY GODWARD KRONISH LLP. dex51.htm EX-5.1 5403
3 CONSENT OF KPMG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. dex231.htm EX-23.1 1784
4 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. dex232.htm EX-23.2 1731
5 GRAPHIC g78205g19c33.jpg GRAPHIC 9982
  Complete submission text file 0001193125-09-179829.txt   63360
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-161485 | Film No.: 091028921
SIC: 2835 In Vitro & In Vivo Diagnostic Substances